Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 CAD | +6.67% | +6.67% | -27.27% |
02/04 | MedMira Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024 | CI |
27/03 | Samsung Pay to stop working with Russia's Mir payment system from April 3 | RE |
Business Summary
Number of employees: 52
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Rapid Diagnostic Products
59.2
%
| 0 | 37.7 % | 0 | 59.2 % | -28.71% |
Rapid Diagnostic Services
40.8
%
| 1 | 62.3 % | 0 | 40.8 % | -70.25% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
87.8
%
| 1 | 94.5 % | 0 | 87.8 % | -57.79% |
Europe
7.1
%
| 0 | 3.8 % | 0 | 7.1 % | -15.77% |
Canada
5.1
%
| 0 | 1.7 % | 0 | 5.1 % | +39.99% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hermes Chan
FOU | Founder | - | 01/93/01 |
Markus Meile
DFI | Director of Finance/CFO | - | 28/10/28 |
Steve Cummings
BRD | Director/Board Member | 60 | 01/07/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hermes Chan
FOU | Founder | - | 01/93/01 |
Steve Cummings
BRD | Director/Board Member | 60 | 01/07/01 |
Markus Meile
DFI | Director of Finance/CFO | - | 28/10/28 |
Pascale Nini
BRD | Director/Board Member | - | 14/22/14 |
Thomas Bergmann
CHM | Chairman | - | 17/21/17 |
Jianhe Mao
BRD | Director/Board Member | - | 31/19/31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 701,730,591 | 208,046,023 ( 29.65 %) | 0 | 29.44 % |
Stock B | 0 | 5,000,000 | 0 | 0 |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-27.27% | 41.13M | |
+8.69% | 220B | |
+6.69% | 183B | |
+10.90% | 133B | |
+25.41% | 107B | |
-0.38% | 63.05B | |
+12.72% | 51.74B | |
+3.96% | 50.47B | |
+0.40% | 40.91B | |
+15.03% | 40.59B |
- Stock Market
- Equities
- MIR Stock
- Company MedMira Inc.